554 related articles for article (PubMed ID: 19479659)
1. The Affymetrix DMET platform and pharmacogenetics in drug development.
Deeken J
Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659
[TBL] [Abstract][Full Text] [Related]
2. DMET microarray technology for pharmacogenomics-based personalized medicine.
Burmester JK; Sedova M; Shapero MH; Mansfield E
Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and the concept of individualized medicine.
Shastry BS
Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics and personalized medicine: the future for drug prescribing.
Mitri Z; Esmerian MO; Simaan JA; Sabra R; Zgheib NK
J Med Liban; 2010; 58(2):101-4. PubMed ID: 20549897
[TBL] [Abstract][Full Text] [Related]
6. Application of microarray technology in psychotropic drug trials.
Murphy GM
J Psychopharmacol; 2006 Jul; 20(4 Suppl):72-8. PubMed ID: 16785274
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics in drug discovery and development: a translational perspective.
Roses AD
Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
[TBL] [Abstract][Full Text] [Related]
8. Personalized medicine: elusive dream or imminent reality?
Lesko LJ
Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacogenetics II. Research molecular methods, bioinformatics and ethical concerns].
Daudén E
Actas Dermosifiliogr; 2007; 98(1):3-13. PubMed ID: 17374327
[TBL] [Abstract][Full Text] [Related]
10. Microelectronic array system for molecular diagnostic genotyping: Nanogen NanoChip 400 and molecular biology workstation.
Keen-Kim D; Grody WW; Richards CS
Expert Rev Mol Diagn; 2006 May; 6(3):287-94. PubMed ID: 16706733
[TBL] [Abstract][Full Text] [Related]
11. Affymetrix GeneChip system: moving from research to the clinic.
Ragoussis J; Elvidge G
Expert Rev Mol Diagn; 2006 Mar; 6(2):145-52. PubMed ID: 16512775
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics/genomics and personalized medicine.
Sadée W; Dai Z
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
[TBL] [Abstract][Full Text] [Related]
13. Developing pharmacogenetic evidence throughout clinical development.
Burns DK
Clin Pharmacol Ther; 2010 Dec; 88(6):867-70. PubMed ID: 20981004
[TBL] [Abstract][Full Text] [Related]
14. DMET-Miner: Efficient discovery of association rules from pharmacogenomic data.
Agapito G; Guzzi PH; Cannataro M
J Biomed Inform; 2015 Aug; 56():273-83. PubMed ID: 26092773
[TBL] [Abstract][Full Text] [Related]
15. Evolution of pharmacogenomics.
Somogy A
Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.
DeVane CL; Stowe ZN; Donovan JL; Newport DJ; Pennell PB; Ritchie JC; Owens MJ; Wang JS
J Psychopharmacol; 2006 Jul; 20(4 Suppl):54-9. PubMed ID: 16785271
[TBL] [Abstract][Full Text] [Related]
17. Personalized medicine.
Jain KK
Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
[TBL] [Abstract][Full Text] [Related]
18. [Genetic polymorphisms on drug metabolizing enzymes in relation to anti-cancer drug effectiveness].
Ozawa S
Rinsho Byori; 2003 Feb; 51(2):168-73. PubMed ID: 12690635
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics in solid organ transplantation: current status and future directions.
de Jonge H; Kuypers DR
Transplant Rev (Orlando); 2008 Jan; 22(1):6-20. PubMed ID: 18631854
[TBL] [Abstract][Full Text] [Related]
20. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
